Max von Kleist
- Infectious Diseases top 5%
- Epidemiology top 10%
- Virology top 2%
- Molecular Biology
- Modeling and Simulation top 5%
- Co-authors
- Christof SchütteWilhelm HuisingaRedmond P. SmythBarbara RathStephan MenzDjin‐Ye OhRoland MarquetSusanne Duwe
- Topics
- HIV Research and Treatment (26 papers)HIV/AIDS Research and Interventions (24 papers)HIV/AIDS drug development and treatment (22 papers)
- Journals
- NatureScienceNucleic Acids Research
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Max von Kleist
76 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 132
- Infectious Diseases 498
- Epidemiology 326
- Virology 295
- Molecular Biology 278
- Modeling and Simulation 94
Countries citing papers authored by Max von Kleist
This map shows the geographic impact of Max von Kleist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max von Kleist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max von Kleist more than expected).
Fields of papers citing papers by Max von Kleist
This network shows the impact of papers produced by Max von Kleist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max von Kleist. The network helps show where Max von Kleist may publish in the future.
Co-authorship network of co-authors of Max von Kleist
This figure shows the co-authorship network connecting the top 25 collaborators of Max von Kleist. A scholar is included among the top collaborators of Max von Kleist based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max von Kleist. Max von Kleist is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | SARS-CoV-2 evolution on a dynamic immune landscapebreakdown → | 17 |
| 4 | 1 | |
| 5 | 34 | |
| 6 | 4 | |
| 7 | 22 | |
| 8 | 15 | |
| 9 | 5 | |
| 10 | 103 | |
| 11 | 4 | |
| 12 | 23 | |
| 13 | 47 | |
| 14 | 13 | |
| 15 | 12 | |
| 16 | 2 | |
| 17 | 11 | |
| 18 | 13 | |
| 19 | 120 | |
| 20 | 30 |
About Max von Kleist
Max von Kleist is a scholar working on Virology, Infectious Diseases and Modeling and Simulation, having authored 79 papers that have together received 1.2k indexed citations. Recurring topics across this work include HIV Research and Treatment (26 papers), HIV/AIDS Research and Interventions (24 papers) and HIV/AIDS drug development and treatment (22 papers). The work is most often cited by research in Virology (295 citations), Infectious Diseases (498 citations) and Modeling and Simulation (94 citations). Max von Kleist has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Christof Schütte, Wilhelm Huisinga, Redmond P. Smyth, Barbara Rath, Stephan Menz, Djin‐Ye Oh, Roland Marquet, Susanne Duwe, David Katzenstein and Richard A. Oberhelman. Their work appears in journals such as Nature, Science and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.